Skip to main content

CG Oncology, Inc.

CGON
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001991792

In the last 90 days, CG Oncology, Inc. insiders filed 1 open-market purchase and 4 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $6.66B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by CG Oncology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $24.8M in total
Open-market sells
4 filings
2 insiders, $2.03M in total
Insiders trading
3
Net value
+$22.8M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for CG Oncology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for CG Oncology, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Post Leonard EDirector0Sep 17, 20269
Mulay JamesDirector0Jul 14, 20268
Liu Brian Guan-ChyunDirector1,886,236IndirectJun 29, 20262
Graf Susan EDirector–Jun 5, 20261
Rossi ChristinaDirector–Jun 5, 20262
Tong Victor Edward JrDirector–Jun 5, 20261
Detore James M.Chief Financial Officer–Apr 16, 20261
Patterson Joshua F.See Remarks–Apr 16, 20261
Bellete AmbawPresident and COO–Apr 16, 20261
Kuan ArthurChief Executive Officer198,916Apr 16, 20263
Kasturi VijayChief Medical Officer1,315Apr 16, 20261
Song Hong FangDirector2,903,931IndirectSep 4, 20250
Roche Corleen M.CFO2,000Apr 16, 20250
Cui Xiangmin10% Owner4,958,810Apr 9, 20240
Decheng Capital Global Life Sciences Fund IV, L.P.10% Owner4,958,810Apr 9, 20240
Decheng Capital Management IV (Cayman), LLC10% Owner4,958,810Apr 9, 20240
Decheng Capital Global Healthcare Fund (Master), LP10% Owner4,958,810Apr 9, 20240
Decheng Capital Global Healthcare GP, LLC10% Owner4,958,810Apr 9, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 17, 2026 (view filing)4:30 PM ETSep 152 daysPost Leonard EDirectorSSale−1.00K$72.98−$73.0K−100.0%0 after10b5-1
Aug 18, 2026 (view filing)4:30 PM ETAug 144 daysPost Leonard EDirectorSSale−1.00K$74.54−$74.5K−100.0%0 after10b5-1
Jul 17, 2026 (view filing)4:15 PM ETJul 152 daysPost Leonard EDirectorSSale−1.00K$71.17−$71.2K−100.0%0 after10b5-1
Jul 14, 2026 (view filing)4:15 PM ETJul 104 daysMulay JamesDirectorSSale−24.2K$75.16−$1.82M−100.0%0 after10b5-1
Jun 29, 2026 (view filing)Jun 254 daysLiu Brian Guan-ChyunDirectorPPurchase+371.1K$66.87+$24.8M+24.5%1.89M after10b5-1
Jun 25, 2026 (view filing)Jun 241 dayPost Leonard EDirectorSSale−5.00K$70.00−$350.0K−100.0%0 after10b5-1
Jun 23, 2026 (view filing)Jun 221 dayPost Leonard EDirectorSSale−5.00K$65.00−$325.0K−100.0%0 after10b5-1
Jun 16, 2026 (view filing)Jun 151 dayMulay JamesDirectorSSale−1.96K$60.12−$118.1K−100.0%0 after2 lots10b5-1
Jun 5, 2026 (view filing)Jun 41 dayPost Leonard EDirectorSSale−1.00K$54.50−$54.5K−100.0%0 after10b5-1
Apr 20, 2026 (view filing)Apr 173 daysMulay JamesDirectorSSale−15.6K$73.01−$1.14M−100.0%0 after10b5-1
Mar 17, 2026 (view filing)Mar 161 dayMulay JamesDirectorSSale−1.96K$63.50−$124.7K−100.0%0 after2 lots10b5-1
Jan 13, 2026 (view filing)Jan 94 daysMulay JamesDirectorSSale−11.1K$52.47−$584.8K−100.0%0 after2 lots10b5-1
Nov 18, 2025 (view filing)Nov 171 dayPost Leonard EDirectorSSale−1.00K$41.43−$41.4K−100.0%0 after10b5-1
Oct 15, 2025 (view filing)Oct 132 daysPost Leonard EDirectorSSale−1.00K$43.25−$43.3K−100.0%0 after10b5-1
Oct 10, 2025 (view filing)Oct 91 dayMulay JamesDirectorSSale−5.90K$43.99−$259.7K−100.0%0 after10b5-1
Oct 1, 2025 (view filing)Sep 301 dayPost Leonard EDirectorSSale−5.00K$40.09−$200.4K−100.0%0 after10b5-1
Sep 30, 2025 (view filing)Sep 291 dayMulay JamesDirectorSSale−12.8K$39.19−$499.9K−100.0%0 after10b5-1
Sep 22, 2025 (view filing)Sep 18-194 daysMulay JamesDirectorSSale−22.7K$39.01−$884.9K−100.0%0 after2 lots10b5-1
Sep 16, 2025 (view filing)Sep 151 dayPost Leonard EDirectorSSale−1.00K$35.10−$35.1K−100.0%0 after10b5-1
Sep 15, 2025 (view filing)Sep 114 daysLiu Brian Guan-ChyunDirectorPPurchase+1.52M$33.00+$50.0MNew position1.52M after10b5-1
Sep 8, 2025 (view filing)Sep 53 daysMulay JamesDirectorSSale−27.0K$31.53−$851.8K−100.0%0 after4 lots10b5-1
Sep 4, 2025 (view filing)Sep 31 daySong Hong FangDirectorSSale−100.0K$27.80−$2.78M−3.3%2.90M after4 lots10b5-1
Sep 4, 2025 (view filing)Sep 31 dayPost Leonard EDirectorSSale−1.00K$28.00−$28.0K−100.0%0 after10b5-1
Jul 18, 2025 (view filing)Jul 171 dayPost Leonard EDirectorSSale−2.00K$28.00−$56.0K−100.0%0 after10b5-1
May 22, 2025 (view filing)May 211 dayPost Leonard EDirectorSSale−1.00K$28.00−$28.0K−100.0%0 after10b5-1
Apr 29, 2025 (view filing)Apr 281 dayPost Leonard EDirectorSSale−1.00K$30.76−$30.8K−100.0%0 after10b5-1
Mar 18, 2025 (view filing)Mar 171 dayPost Leonard EDirectorSSale−1.00K$28.00−$28.0K−100.0%0 after10b5-1
Feb 19, 2025 (view filing)Feb 181 dayPost Leonard EDirectorSSale−1.00K$28.61−$28.6K−100.0%0 after10b5-1
Jan 14, 2025 (view filing)Jan 131 dayPost Leonard EDirectorSSale−1.00K$29.66−$29.7K−100.0%0 after10b5-1
Dec 17, 2024 (view filing)Dec 161 daySong Hong FangDirectorSSale−700.0K$28.00−$19.6M−18.9%3.00M after
Dec 17, 2024 (view filing)Dec 161 dayPost Leonard EDirectorSSale−1.00K$28.84−$28.8K−100.0%0 after10b5-1
Dec 6, 2024 (view filing)Dec 6Same dayPost Leonard EDirectorSSale−1.00K$34.55−$34.5K−100.0%0 after2 lots10b5-1
Aug 30, 2024 (view filing)Aug 291 daySong Hong FangDirectorSSale−650.5K$35.36−$23.0M−14.9%3.70M after2 lots
Apr 9, 2024 (view filing)7:08 PM ETJan 2971 daysCui Xiangmin and 4 others10% OwnerPPurchase+400.0K$19.00+$7.60M+8.8%4.96M afterAmended
Jan 31, 2024 (view filing)Jan 292 daysKasturi VijayChief Medical OfficerPPurchase+1.31K$19.00+$25.0KNew position1.31K after
Jan 31, 2024 (view filing)Jan 292 daysRoche Corleen M.CFO & SecretaryPPurchase+2.00K$19.00+$38.0KNew position2.00K after
Jan 31, 2024 (view filing)Jan 292 daysSong Hong FangDirectorPPurchase+263.2K$19.00+$5.00M+75.0%613.9K after